SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2015

Schedule of Segment Reporting Information, by Segment

The following table shows revenue and gross profit by reportable operating segment for the three months ended March 31, 2015 and 2014 (in thousands):



	Three Months Ended March 31,
	2015		2014
Revenue:
Affymetrix Core	$	64,445	$	59,447
eBioscience	24,272		23,524
Total revenue	$	88,717	$	82,971
Gross Profit:
Affymetrix Core	$	40,627	$	35,004
eBioscience	14,211		11,551
Total gross profit	$	54,838	$	46,555

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details